Sermorelin is a peptide related to the first 29 amino acids of growth hormone-releasing hormone, or GHRH(1-29). This sequence contains key elements required for activation of the GHRH receptor and is used in studies of pituitary GH signaling.
GHRH receptor response
The GHRH receptor belongs to the G-protein-coupled receptor family. Activation is often monitored through cAMP and downstream signaling. More complex models may examine the dynamics of GH signals and their relationship with the IGF-1 axis.
Research endpoints
- GHRH receptor affinity and functional activity
- cAMP generation
- enzymatic degradation and experimental stability
- structure-activity relationships
- comparison with longer GHRH analogs
Sermorelin and GRF 1-29
The terms frequently appear in related contexts. Researchers should verify the exact sequence, chemical form and experimental conditions because small structural differences can affect stability and assay results.
Related laboratory material
See the neutrally labeled GRF 1-29 Peptide 5 mg and Sermorelin vs Tesamorelin.
Further reading
PubMed: sermorelin and GHRH(1-29)
RESEARCH USE ONLY: This educational content concerns laboratory and scientific research. Peptiva research materials are not medicines and are not intended for use in humans or animals.